Pharmaceutical Industry Use Case
Developing medicines to treat asthma can be time consuming and a complex process. This is especially true in pediatric medicine where children prefer oral alternatives to inhalers.
Formulators frequently start with baseline ingredient, montelukast sodium (CAS RN 151767-02-1) to make these drugs. To encourage patient compliance, it is necessary to include excipients specifically to help make montelukast sodium palatable.. Learn how Formulus can help speed up the process.